403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Knight Therapeutics Inc.
(MENAFN- Baystreet) 10:16 AM EST - Knight Therapeutics Inc. : Today reported financial results for its fourth quarter ended December 31, 2024. Revenues were $371,304, an increase of $43,105 or 13% over the prior year. Net income was $4,332, compared to a net loss $16,835 in prior year. Knight Therapeutics Inc.
shares T are trading up $0.17 at $6.42.
shares T are trading up $0.17 at $6.42.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment